Caribbean experts issue WNV surveillance guidelines:
This article was originally published in Clinica
Executive Summary
Canadian company Medical Services International is claiming a "100% accuracy" rate in an assessment of its VScan HIV I and II test kits in Haiti, in support of its campaign to extend provision of the test across the Caribbean. Medical Services believes its kit is particularly useful to the Caribbean market for being "very affordable and well suited for poorer countries", such as because it does not need to be refrigerated, does not need to be mixed, can be easily transported and provides results at the point of care.
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.